Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
27, Supplementary Tables 2, 3)
doi:10.1016/j.ejphar.2020.173368 Yilmaz H, Sahin S, Sayar N, et al
FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the interaction between the FOXO4 transcription factor and p53, a key mechanism that senescent cells exploit to resist apoptosis
Shanghai Science and Technology Committee (19ZR1467500 to H.M.)
Therefore, we predict that both mechanisms will have a role in modulating tumour 5FU sensitivity
Semaglutide and cardiovascular outcomes by baseline characteristics SELECT trial
US$ 20.50
US$ 22.46
US$ 26.21
US$ 21.32
US$ 25.22
US$ 21.83
US$ 25.43
US$ 29.32
US$ 21.47
